Variant report

Variant	rs9820116
Chromosome Location	chr3:50336492-50336493
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	POLR2A	chr3:50335795-50338360	HepG2	liver:	n/a	n/a
2	SP1	chr3:50336328-50337316	A549	lung:	n/a	chr3:50337065-50337077 chr3:50336965-50336977 chr3:50336896-50336908 chr3:50337065-50337077 chr3:50337066-50337075 chr3:50336380-50336390 chr3:50337097-50337106 chr3:50337098-50337111 chr3:50337097-50337106 chr3:50337096-50337108 chr3:50336381-50336390 chr3:50336965-50336977 chr3:50336913-50336922 chr3:50337066-50337080 chr3:50336380-50336390 chr3:50337097-50337107 chr3:50337096-50337108 chr3:50337098-50337107 chr3:50336897-50336906 chr3:50337067-50337076 chr3:50336380-50336389 chr3:50336896-50336908 chr3:50336379-50336391 chr3:50336379-50336391 chr3:50336367-50336379 chr3:50336440-50336454 chr3:50336966-50336980 chr3:50336368-50336378
3	TCF12	chr3:50336219-50337339	ECC-1	luminal epithelium:	n/a	chr3:50337141-50337151 chr3:50337076-50337083 chr3:50337308-50337317
4	POLR2A	chr3:50336384-50337006	GM12892	blood:	n/a	n/a
5	TAF1	chr3:50336448-50337316	H1-neurons	neurons:	n/a	n/a
6	MAX	chr3:50336168-50337372	GM12878	blood:	n/a	chr3:50336440-50336450 chr3:50336380-50336390
7	CTCF	chr3:50336460-50336610	WERI-Rb-1	eye:	n/a	n/a
8	MXI1	chr3:50336202-50337319	GM12878	blood:	n/a	n/a
9	TBP	chr3:50336234-50337747	Hela-S3	cervix:	n/a	n/a
10	POLR2A	chr3:50336255-50336935	GM12892	blood:	n/a	n/a
11	TCF12	chr3:50336374-50336716	A549	lung:	n/a	n/a
12	MXI1	chr3:50336304-50337968	Hela-S3	cervix:	n/a	n/a
13	POLR2A	chr3:50335828-50337929	HepG2	liver:	n/a	n/a
14	E2F6	chr3:50336264-50336931	A549	lung:	n/a	n/a
15	POLR2A	chr3:50336044-50338389	HepG2	liver:	n/a	n/a
16	POLR2A	chr3:50336094-50337984	GM19099	blood:	n/a	n/a
17	ZNF143	chr3:50336313-50336870	K562	blood:	n/a	n/a
18	POLR2A	chr3:50336101-50338003	HCT-116	colon:	n/a	n/a
19	POLR2A	chr3:50335773-50338119	K562	blood:	n/a	n/a
20	POLR2A	chr3:50335711-50338284	HL-60	blood:	n/a	n/a
21	POLR2A	chr3:50336174-50337537	ECC-1	luminal epithelium:	n/a	n/a
22	HDAC2	chr3:50336181-50336784	HepG2	liver:	n/a	chr3:50336591-50336600
23	NRF1	chr3:50336232-50337652	SK-N-SH	brain:	n/a	chr3:50336380-50336389
24	SIN3AK20	chr3:50336488-50336818	A549	lung:	n/a	n/a
25	MAX	chr3:50336380-50337453	A549	lung:	n/a	chr3:50336440-50336450 chr3:50336380-50336390
26	POLR2A	chr3:50335760-50338326	HepG2	liver:	n/a	n/a
27	POLR2A	chr3:50336232-50336953	HCT-116	colon:	n/a	n/a
28	SP1	chr3:50336064-50337371	H1-hESC	embryonic stem cell:	n/a	chr3:50337065-50337077 chr3:50336202-50336214 chr3:50336965-50336977 chr3:50336896-50336908 chr3:50337065-50337077 chr3:50337066-50337075 chr3:50336380-50336390 chr3:50337097-50337106 chr3:50337098-50337111 chr3:50337097-50337106 chr3:50336204-50336213 chr3:50337096-50337108 chr3:50336381-50336390 chr3:50336965-50336977 chr3:50336203-50336217 chr3:50336913-50336922 chr3:50337066-50337080 chr3:50336380-50336390 chr3:50337097-50337107 chr3:50337096-50337108 chr3:50337098-50337107 chr3:50336897-50336906 chr3:50337067-50337076 chr3:50336380-50336389 chr3:50336896-50336908 chr3:50336379-50336391 chr3:50336379-50336391 chr3:50336367-50336379 chr3:50336440-50336454 chr3:50336966-50336980 chr3:50336368-50336378
29	ZNF143	chr3:50336345-50337219	GM12878	blood:	n/a	n/a
30	RELA	chr3:50336146-50337026	GM10847	blood:	n/a	n/a
31	POLR2A	chr3:50336048-50337467	GM18505	blood:	n/a	n/a
32	CREB1	chr3:50336345-50337502	K562	blood:	n/a	n/a
33	HCFC1	chr3:50335896-50338321	Hela-S3	cervix:	n/a	n/a
34	ETS1	chr3:50336127-50336896	K562	blood:	n/a	chr3:50336293-50336308
35	IRF1	chr3:50336194-50337419	K562	blood:	n/a	chr3:50337063-50337077 chr3:50336894-50336908 chr3:50336379-50336393 chr3:50336963-50336977 chr3:50337094-50337108
36	MAX	chr3:50336336-50337521	K562	blood:	n/a	chr3:50336440-50336450 chr3:50336380-50336390
37	CHD1	chr3:50336264-50336804	GM12878	blood:	n/a	n/a
38	RCOR1	chr3:50335885-50337415	K562	blood:	n/a	n/a
39	POLR2A	chr3:50336362-50337322	H1-hESC	embryonic stem cell:	n/a	n/a
40	SIN3A	chr3:50336248-50337333	H1-hESC	embryonic stem cell:	n/a	chr3:50336813-50336822 chr3:50337088-50337101
41	SP4	chr3:50336159-50336892	H1-hESC	embryonic stem cell:	n/a	chr3:50336377-50336393
42	MAZ	chr3:50336250-50337256	HepG2	liver:	n/a	chr3:50336440-50336450 chr3:50336380-50336390
43	CTCF	chr3:50336477-50336881	GM12891	blood:	n/a	n/a
44	SIN3AK20	chr3:50336189-50336926	PANC-1	pancreas:	n/a	n/a
45	POLR2A	chr3:50336073-50337348	GM19193	blood:	n/a	n/a
46	E2F4	chr3:50336379-50337323	K562	blood:	n/a	chr3:50337232-50337241 chr3:50337128-50337139 chr3:50337284-50337294 chr3:50337234-50337243 chr3:50337067-50337076 chr3:50337062-50337072
47	SIN3AK20	chr3:50336153-50336967	K562	blood:	n/a	n/a
48	JUND	chr3:50335875-50337502	K562	blood:	n/a	chr3:50336924-50336936 chr3:50337233-50337242
49	POLR2A	chr3:50336420-50337044	ProgFib	skin:	n/a	n/a
50	CREB1	chr3:50336299-50337465	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr10:96305128..96305906-chr3:50336255..50337029,2	Hela-S3	cervix:
2	chr15:83418706..83419650-chr3:50336333..50336903,2	Hela-S3	cervix:
3	chr3:50308810..50310913-chr3:50335251..50336783,2	MCF-7	breast:
4	chr3:50296030..50318456-chr3:50318822..50339499,66	MCF-7	breast:
5	chr3:50334511..50339320-chr3:50364012..50367102,8	MCF-7	breast:
6	chr3:50335402..50338508-chr3:50371973..50376083,5	K562	blood:
7	chr3:50310399..50313142-chr3:50335615..50338582,3	K562	blood:
8	chr15:59041650..59042242-chr3:50336459..50337109,2	Hela-S3	cervix:
9	chr3:50327926..50342388-chr3:50350886..50359960,36	MCF-7	breast:
10	chr2:10589361..10589892-chr3:50336432..50336956,2	Hela-S3	cervix:
11	chr3:50324564..50342616-chr3:50350801..50362499,49	MCF-7	breast:
12	chr1:150551439..150552084-chr3:50336152..50336806,2	NB4	blood:
13	chr12:6561022..6561774-chr3:50336490..50337057,2	NB4	blood:
14	chr3:50334885..50342502-chr3:50352987..50366859,26	K562	blood:
15	chr3:50295925..50299690-chr3:50335868..50338319,4	K562	blood:
16	chr3:50333907..50338508-chr3:50371973..50376030,7	K562	blood:
17	chr3:50297731..50299690-chr3:50335668..50338319,3	K562	blood:
18	chr3:50335131..50340487-chr3:50360694..50367461,13	K562	blood:
19	chr3:50335266..50337009-chr6:27114656..27117147,2	K562	blood:
20	chr3:50334334..50341950-chr3:50357130..50360296,11	K562	blood:
21	chr3:50336373..50338366-chr3:50377598..50379105,2	K562	blood:
22	chr3:50272615..50275191-chr3:50335158..50337593,2	MCF-7	breast:

Variant related genes	Relation type
NAT6	TF binding region
HYAL3	TF binding region
ENSG00000068028	Chromatin interaction
ENSG00000230454	Chromatin interaction
ENSG00000012171	Chromatin interaction
ENSG00000250988	Chromatin interaction
ENSG00000143384	Chromatin interaction
ENSG00000139192	Chromatin interaction
ENSG00000184825	Chromatin interaction
ENSG00000179564	Chromatin interaction
ENSG00000232352	Chromatin interaction
ENSG00000114383	Chromatin interaction
ENSG00000235058	Chromatin interaction
ENSG00000137845	Chromatin interaction
ENSG00000257135	Chromatin interaction
ENSG00000068001	Chromatin interaction
ENSG00000265565	Chromatin interaction
ENSG00000119969	Chromatin interaction
ENSG00000114353	Chromatin interaction

Extended variants
information (count: 45 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:18)

rs_ID	r²[population]
rs12330297	0.87[AFR][1000 genomes]
rs13316958	1.00[AFR][1000 genomes]
rs13321551	1.00[AFR][1000 genomes]
rs13323932	1.00[AFR][1000 genomes]
rs13324545	0.87[AFR][1000 genomes]
rs13327678	1.00[AFR][1000 genomes]
rs9811223	1.00[AFR][1000 genomes]
rs9825506	1.00[AFR][1000 genomes]
rs9828683	0.87[AFR][1000 genomes]
rs9829573	1.00[AFR][1000 genomes]
rs9835838	1.00[AFR][1000 genomes]
rs9849605	0.87[AFR][1000 genomes]
rs9850145	1.00[AFR][1000 genomes]
rs9860546	1.00[AFR][1000 genomes]
rs9864231	0.87[AFR][1000 genomes]
rs9866016	0.87[AFR][1000 genomes]
rs9875449	0.89[AFR][1000 genomes]
rs9883977	1.00[AFR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:27 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv523662	chr3:50144951-50584999	Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	101 gene(s)	inside rSNPs	diseases
2	nsv1013949	chr3:50151712-50339163	Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer Genic enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
3	nsv876769	chr3:50155468-50408398	Active TSS Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
4	esv1821728	chr3:50156142-50657253	Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	109 gene(s)	inside rSNPs	diseases
5	esv1793751	chr3:50157364-50476363	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
6	esv1828162	chr3:50157364-50506151	Enhancers Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
7	nsv590251	chr3:50158774-50337422	Active TSS Strong transcription Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
8	nsv470561	chr3:50158774-50584999	Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	99 gene(s)	inside rSNPs	diseases
9	nsv876770	chr3:50158774-50609624	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
10	nsv523560	chr3:50172397-50339163	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Genic enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
11	nsv1014256	chr3:50187646-50339163	Enhancers Active TSS Strong transcription Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
12	nsv536565	chr3:50187646-50339163	Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
13	nsv1001993	chr3:50187646-50640808	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
14	nsv590253	chr3:50196418-50337422	Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Enhancers Strong transcription Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
15	esv2757870	chr3:50198478-50371377	Genic enhancers Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
16	esv2759148	chr3:50198478-50371377	Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
17	nsv834692	chr3:50198485-50393464	Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
18	nsv590254	chr3:50243510-50388607	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
19	nsv460531	chr3:50247824-50436827	Strong transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Active TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
20	nsv590255	chr3:50247824-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
21	nsv876772	chr3:50255305-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
22	nsv590257	chr3:50302830-50393640	Genic enhancers Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	82 gene(s)	inside rSNPs	diseases
23	nsv590256	chr3:50302830-50420554	Weak transcription Enhancers Active TSS Strong transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	83 gene(s)	inside rSNPs	diseases
24	nsv876774	chr3:50302830-50436827	Enhancers Strong transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	83 gene(s)	inside rSNPs	diseases
25	nsv876773	chr3:50302830-50480131	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
26	nsv834693	chr3:50302830-50507964	Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
27	nsv876775	chr3:50324672-50504896	Flanking Active TSS Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	82 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:127 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:50332400-50336600	Transcr. at gene 5' and 3'	Foreskin Fibroblast Primary Cells skin02	Skin
2	chr3:50335200-50336600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
3	chr3:50335200-50338000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
4	chr3:50335400-50336600	Flanking Active TSS	Primary hematopoietic stem cells	blood
5	chr3:50335400-50336600	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
6	chr3:50335400-50336600	Flanking Active TSS	Brain Germinal Matrix	brain
7	chr3:50335600-50336600	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
8	chr3:50335600-50336600	Flanking Active TSS	Muscle Satellite Cultured Cells	--
9	chr3:50335600-50336600	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
10	chr3:50335600-50336600	Flanking Active TSS	Brain Cingulate Gyrus	brain
11	chr3:50335600-50336600	Flanking Active TSS	Duodenum Mucosa	Duodenum
12	chr3:50335600-50336600	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
13	chr3:50335600-50336800	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
14	chr3:50335600-50336800	Flanking Active TSS	Primary mononuclear cells fromperipheralblood	Blood
15	chr3:50335600-50336800	Flanking Active TSS	Adipose Nuclei	Adipose
16	chr3:50335600-50336800	Flanking Active TSS	Dnd41	blood
17	chr3:50335600-50336800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
18	chr3:50335600-50337200	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
19	chr3:50335600-50337400	Active TSS	Brain Inferior Temporal Lobe	brain
20	chr3:50335800-50336600	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr3:50335800-50336600	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
22	chr3:50335800-50336600	Flanking Active TSS	Primary T cells fromperipheralblood	blood
23	chr3:50335800-50336600	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
24	chr3:50335800-50336600	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
25	chr3:50335800-50336600	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
26	chr3:50335800-50336600	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
27	chr3:50335800-50336600	Flanking Active TSS	Brain Substantia Nigra	brain
28	chr3:50335800-50336600	Flanking Active TSS	Fetal Brain Male	brain
29	chr3:50335800-50336600	Flanking Active TSS	Fetal Intestine Small	intestine
30	chr3:50335800-50336600	Flanking Active TSS	Fetal Muscle Leg	muscle
31	chr3:50335800-50336600	Flanking Active TSS	Fetal Stomach	stomach
32	chr3:50335800-50336600	Flanking Active TSS	Fetal Thymus	thymus
33	chr3:50335800-50336600	Flanking Active TSS	Rectal Smooth Muscle	rectum
34	chr3:50335800-50336600	Flanking Active TSS	Stomach Mucosa	stomach
35	chr3:50335800-50336600	Flanking Active TSS	HUVEC	blood vessel
36	chr3:50335800-50336600	Flanking Active TSS	Osteobl	bone
37	chr3:50335800-50336800	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
38	chr3:50335800-50336800	Flanking Active TSS	Fetal Muscle Trunk	muscle
39	chr3:50335800-50336800	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
40	chr3:50335800-50336800	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
41	chr3:50335800-50336800	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
42	chr3:50335800-50337200	Active TSS	HUES48 Cell Line	embryonic stem cell
43	chr3:50335800-50337200	Active TSS	iPS-18 Cell Line	embryonic stem cell
44	chr3:50335800-50337200	Active TSS	iPS-20b Cell Line	embryonic stem cell
45	chr3:50335800-50337400	Active TSS	H9 Cell Line	embryonic stem cell
46	chr3:50335800-50337400	Active TSS	HUES64 Cell Line	embryonic stem cell
47	chr3:50335800-50337400	Active TSS	HSMMtube	muscle
48	chr3:50335800-50338200	Flanking Active TSS	Stomach Smooth Muscle	stomach
49	chr3:50336000-50336600	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
50	chr3:50336000-50336600	Flanking Active TSS	Primary B cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links